摘要
目的 :分析脑部肿瘤患者围手术期用血情况,为临床科学合理用血提供依据。方法 :收集2014年1月至12月华山医院脑部肿瘤围手术期用血患者101例,按年龄分为青年组(18-39岁)13例,中年组(40-59岁)50例,老年组(60-80岁)38例。回顾性分析三组围手术期临床输血资料。结果 :在围手术期用血中,脑膜瘤患者占47.52%(48/101),其次为胶质瘤和转移瘤患者,分别占19.80%(20/101)和10.89%(11/101)。脑部肿瘤围手术期用血患者主要集中在中年组,占49.50%(50/101);48例脑膜瘤患者总计输注红细胞170 U,血浆282 U,血小板11 U,占各类脑部肿瘤患者的首位。围手术期青年组、中年组和老年组例均输注红细胞量分别为2.43 U、3.2 U和3.67 U。结论 :随患者年龄增大,红细胞用量均呈上升趋势,故应重视中、老年患者的围术期血液管理工作。
Objective: To analyze blood transfusion for patients with brain tumor in perioperative period and set the scientific and rational principle for clinical blood transfusion. Methods: One hundred and one patiens with brain tumor were enrolled from January to December 2014 in Huashan hospital. The patients were divided into the young(aged from 18 to 39 years,13 cases), middle(aged from 40 to 59 years, 50 cases), and elderly(aged from 60 to 80 years, 38 cases) groups. The blood transfusion data of three groups in perioperative period were retrospectively analyzed. Results: Among patients receiving blood transfusion in perioperative period,those with meningioma acounted for 47.52%(48/101), meningioma glioma 19.80%(20/101) and metastatic tumor 10.89%(11/101). The patients in middle-aged group acounted for 49.50%(50/101) in patients receiving blood transfusion in perioperative period. Forty eight patients with meningioma received 170 U of the red blood cells, 282 U of the plasma and 11 U of the platelet,which were higher than other patients with brain tumor. The average transfusion of the red blood cells was 2.43 U, 3.2 U and 3.67 U per person in the young,middle-aged and elderly groups, respectively. Conclusion: The transfusion of the red blood cells is increasing with aging of the patients. It is necessary to pay more attention to the blood management of the middle-aged and the elderly patients in perioperative period.
出处
《上海医药》
CAS
2015年第14期7-9,共3页
Shanghai Medical & Pharmaceutical Journal
基金
国家自然科学基金面上项目(81170530)
关键词
脑肿瘤
围手术期
输血
brain tumor
perioperative period
blood transfusion